GlassScriptPhysician profile
Shreya Sinha
NPI 1295170793
$2,902.65
in general payments reported to CMS, 2019-2025
40 companies · $1,108 in 2025
The $1,108 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50.98 · 2020: $50.24 · 2021: $44.00 · 2023: $380 · 2024: $1,270 · 2025: $1,108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,725 · Education: $32.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,725.09 |
| Education | $32.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $319.87 | 2023-2025 | |
| Glaxosmithkline, LLC. | $294.51 | 2023-2025 | Jemperli, Zejula |
| Regeneron Healthcare Solutions, INC. | $164.27 | 2024-2025 | Libtayo |
| Incyte Corporation | $145.25 | 2023-2025 | Jakafi, Monjuvi, Niktimvo |
| Merck Sharp & Dohme LLC | $141.81 | 2023-2025 | Keytruda |
| Abbvie INC. | $139.57 | 2024-2025 | |
| Array Biopharma INC | $134.51 | 2024-2025 | Braftovi, Mektovi, Tukysa |
| Janssen Biotech, INC. | $131.63 | 2023-2024 | Rybrevant, Darzalex, Talvey |
| Caris Mpi, INC. | $123.82 | 2025 | Mi Cancer Seek |
| Pfizer INC. | $119.83 | 2024 | |
| Intera Oncology, INC | $114.21 | 2024 | Intera |
| E.R. Squibb & Sons, L.L.C. | $101.71 | 2020-2024 | Opdivo |
| Aveo Pharmaceuticals, INC. | $73.15 | 2023-2025 | Fotivda |
| Astrazeneca Pharmaceuticals LP | $69.02 | 2019-2024 | Imfinzi |
| Astellas Pharma US INC | $67.58 | 2020-2025 | Padcev, Xtandi |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shreya Sinha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.